GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Health and Happiness (H&H) International Holdings 1112.HK · HKD

Consumer Staples · HKEX · 🇭🇰 Hong Kong

Compare

25.24

+1.53%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥16.70bn

FY2016FY2025

Net income

CN¥228.3m

FY2016FY2025

Free cash flow

CN¥1.10bn

FY2016FY2025

Shareholders' equity

CN¥6.97bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥16.70bnCN¥15.19bnCN¥16.21bnCN¥14.87bnCN¥13.44bnCN¥13.03bnCN¥12.71bnCN¥11.79bnCN¥9.42bnCN¥7.57bn
Gross profitCN¥10.43bnCN¥9.21bnCN¥9.86bnCN¥8.97bnCN¥8.43bnCN¥8.36bnCN¥8.41bnCN¥7.84bnCN¥6.13bnCN¥4.72bn
Research and developmentCN¥251.6mCN¥282.8mCN¥239.8mCN¥184.1mCN¥167.5mCN¥161.7mCN¥190.5mCN¥175.9mCN¥114.8mCN¥89.9m
Operating incomeCN¥1.82bnCN¥1.24bnCN¥2.03bnCN¥1.87bnCN¥1.30bnCN¥2.07bnCN¥2.31bnCN¥2.29bnCN¥2.10bnCN¥1.97bn
Net incomeCN¥228.3m−CN¥62.5mCN¥677.1mCN¥712.0mCN¥591.8mCN¥1.32bnCN¥1.17bnCN¥981.2mCN¥1.09bnCN¥1.11bn
Diluted earnings per share0.36-0.101.051.110.922.051.821.511.691.75

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥22.59bnCN¥21.93bnCN¥23.32bnCN¥24.40bnCN¥23.60bnCN¥20.04bnCN¥18.46bnCN¥17.29bnCN¥16.45bnCN¥16.53bn
Cash and short-term investmentsCN¥2.01bnCN¥1.87bnCN¥1.69bnCN¥2.68bnCN¥2.79bnCN¥2.13bnCN¥2.58bnCN¥2.23bnCN¥2.43bnCN¥1.75bn
Total liabilitiesCN¥15.62bnCN¥15.16bnCN¥16.00bnCN¥17.25bnCN¥16.75bnCN¥12.82bnCN¥11.95bnCN¥11.64bnCN¥11.54bnCN¥12.81bn
DebtCN¥10.53bnCN¥9.36bnCN¥9.22bnCN¥9.67bnCN¥9.48bnCN¥6.17bnCN¥6.04bnCN¥5.97bnCN¥6.28bnCN¥6.76bn
Shareholders' equityCN¥6.97bnCN¥6.77bnCN¥7.33bnCN¥7.15bnCN¥6.85bnCN¥7.22bnCN¥6.51bnCN¥5.64bnCN¥4.90bnCN¥3.68bn
Shares outstanding642m641m646m644m645m644m643m650m641m634m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.16bnCN¥1.57bnCN¥1.28bnCN¥1.71bnCN¥2.20bnCN¥1.78bnCN¥1.67bnCN¥1.98bnCN¥2.27bnCN¥1.80bn
Capital spending−CN¥55.0m−CN¥113.2m−CN¥105.9m−CN¥119.3m−CN¥124.1m−CN¥123.9m−CN¥154.4m−CN¥305.3m−CN¥679.7m−CN¥102.9m
Free cash flowCN¥1.10bnCN¥1.45bnCN¥1.17bnCN¥1.59bnCN¥2.08bnCN¥1.66bnCN¥1.52bnCN¥1.67bnCN¥1.59bnCN¥1.69bn
Dividends paid−CN¥160.4m−CN¥328.1m−CN¥552.2m−CN¥271.9m−CN¥474.3m−CN¥1.00bn−CN¥316.0m−CN¥316.0m−CN¥316.0m—

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥9.98bnCN¥8.54bnCN¥8.17bnCN¥7.40bnCN¥7.79bnCN¥8.08bnCN¥8.12bnCN¥7.94bn
Gross profitCN¥6.53bnCN¥5.32bnCN¥5.11bnCN¥4.42bnCN¥4.79bnCN¥4.90bnCN¥4.96bnCN¥4.67bn
Operating incomeCN¥2.11bnCN¥869.0mCN¥1.07bnCN¥720.6mCN¥1.11bnCN¥824.4mCN¥1.29bnCN¥801.9m
Net incomeCN¥700.8mCN¥145.6mCN¥82.6m−CN¥418.4mCN¥355.9m−CN¥30.5mCN¥707.6mCN¥159.1m
Diluted earnings per share1.090.230.13-0.650.55-0.051.090.25
Cash from operationsCN¥1.64bnCN¥300.0mCN¥1.16bnCN¥342.0mCN¥1.22bnCN¥1.25bnCN¥25.0mCN¥1.06bn
Capital spending−CN¥32.0m−CN¥28.0m−CN¥28.0m−CN¥87.0m−CN¥25.0m−CN¥34.0m−CN¥33.0m−CN¥21.0m
Free cash flowCN¥1.61bnCN¥272.0mCN¥1.13bnCN¥255.0mCN¥1.20bnCN¥1.22bn−CN¥8.0mCN¥1.04bn
Total assetsCN¥22.67bnCN¥22.59bnCN¥22.57bnCN¥21.93bnCN¥23.66bnCN¥23.32bnCN¥24.88bnCN¥24.40bn
Cash and short-term investmentsCN¥2.32bnCN¥2.01bnCN¥2.11bnCN¥1.87bnCN¥2.83bnCN¥1.59bnCN¥2.49bnCN¥2.68bn
DebtCN¥2.13bnCN¥10.53bnCN¥10.83bnCN¥10.89bnCN¥11.16bnCN¥10.73bnCN¥11.86bnCN¥11.25bn
Shareholders' equityCN¥7.58bnCN¥6.97bnCN¥6.99bnCN¥6.77bnCN¥7.52bnCN¥7.33bnCN¥7.75bnCN¥7.15bn

Financial ratios

Data as of 9 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin62.4%60.6%60.8%60.3%62.8%64.2%
Operating margin10.9%8.2%12.5%12.2%9.6%16.5%
Net margin1.4%-0.4%4.2%4.8%4.4%10.2%
Return on equity3.3%-0.9%9.2%10.0%8.6%18.3%
Return on assets1.0%-0.3%2.9%2.9%2.5%6.6%
Free cash flow yield8.0%11.1%9.1%12.0%15.3%12.5%
Revenue growth10.0%-6.3%9.0%10.6%3.2%2.5%
Earnings growth-465.1%-109.2%-4.9%20.3%-55.3%13.1%
Current ratio1.15x1.19x0.61x1.14x0.81x1.52x
Debt to equity1.49x1.60x1.45x1.56x1.60x0.97x
Equity ratio30.9%30.9%31.4%29.3%29.0%36.0%
Interest coverage2.28x1.23x2.16x2.94x4.22x7.58x
R&D as a share of sales1.5%1.9%1.5%1.2%1.2%1.2%
Buybacks as a share of market value-0.1%0.8%-0.3%0.1%-0.1%-0.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.0%5.1%11.5%
Operating income-1.0%-2.6%9.0%
Net income-31.6%-29.6%-2.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin61.6%61.1%61.8%62.9%
Operating margin9.6%11.0%11.5%14.5%
Net margin0.5%2.5%3.9%5.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings32.3-79.410.113.211.512.215.525.926.812.0
Price to sales0.40.30.40.60.51.21.42.23.11.8

Dividends and splits

Per share, in the currency the company pays

Paid for 7 years. Last went ex-dividend on 19 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.160.240.540.820.420.761.480.48

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.